Koning Health Announces Expansion of Vera Scan Installations Across the United States

NORCROSS, Ga., April 1, 2025 /PRNewswire/ -- Koning Health proudly announces its continued nationwide expansion, with new installations of the Vera Scan coming soon to eight prominent locations across the United States.

The Vera Scan, Koning's innovative breast imaging device that delivers superior imaging accuracy without painful compression, is scheduled to be available in these locations in the coming months:

Naperville, Illinois
Sarasota, Florida
St. Louis, Missouri
Nashville, Tennessee
Boca Raton, Florida
Dalton, Georgia
Upper East Side, New York City
Long Island, New York

This expansion represents Koning's commitment to making advanced breast cancer imaging accessible to women nationwide, offering early detection with greater comfort and precision. By expanding into these vital regions, Koning continues to fulfill its mission to revolutionize breast health, improve compliance rates, and through early treatment improve patient outcomes.

"Our expansion has been exponential in recent months," said Lutao Ning, CEO at Koning Health. "Bringing the Vera Scan technology to these vibrant communities aligns with our vision of empowering women through innovation and compassion. We're excited to partner with local healthcare providers to deliver an improved patient experience and ultimately save more lives through early detection."

Stay tuned for more information on official openings, ribbon-cutting ceremonies, community events, and exclusive first-look opportunities at each new installation location.

About Koning:Koning is a global Health Technology company focused on improving the breast imaging industry with its patented Koning Vera Breast CT (KBCT). Koning's vision is to create a revolution in medical imaging through advanced computed tomography technology that dramatically improves the way clinicians visualize and evaluate breast tissue. The Koning Vera is expected to optimize early disease detection, diagnosis, and intervention by the clinician. For more information, please visitKoning'swebsite or email Koning at [emailprotected].

SOURCE KONING CORPORATION